ITU Unit Action

EXCITE

Novartis AG

ITU Unit Action

Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	86028397	FILING DATE	08/05/2013
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	SERVICE MARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	MARTIN, CHRISTINE C	L.O. ASSIGNED	104

PUB INFORMATION
RUN DATE	09/03/2015
PUB DATE	07/01/2014
STATUS	731-SECOND EXTENSION - GRANTED
STATUS DATE	09/02/2015
LITERAL MARK ELEMENT	EXCITE

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	YES
LITERAL MARK ELEMENT	EXCITE
MARK DRAWING CODE	4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Novartis AG
ADDRESS	CH-4002 Basel,
ENTITY	03-CORPORATION
CITIZENSHIP	Switzerland

GOODS AND SERVICES
INTERNATIONAL CLASS	042
DESCRIPTION TEXT	Medical and scientific research in the field of diabetes and conducting clinical trials for medical and research professionals; Providing medical and scientific research information in the field of clinical trials

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	042	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
09/03/2015	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	025
09/02/2015	EX2G	S	EXTENSION 2 GRANTED	024
08/19/2015	EXT2	S	EXTENSION 2 FILED	023
08/30/2015	AITU	A	CASE ASSIGNED TO INTENT TO USE PARALEGAL	022
08/19/2015	EEXT	I	TEAS EXTENSION RECEIVED	021
02/21/2015	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	020
02/19/2015	EX1G	S	EXTENSION 1 GRANTED	019
02/19/2015	EXT1	S	EXTENSION 1 FILED	018
02/19/2015	EEXT	I	TEAS EXTENSION RECEIVED	017
08/26/2014	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	016
07/01/2014	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	015
07/01/2014	PUBO	A	PUBLISHED FOR OPPOSITION	014
06/11/2014	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	013
05/26/2014	PREV	O	LAW OFFICE PUBLICATION REVIEW COMPLETED	012
05/26/2014	ALIE	A	ASSIGNED TO LIE	011
05/13/2014	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	010
04/23/2014	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	009
04/23/2014	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	008
04/23/2014	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	007
11/12/2013	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	006
11/12/2013	GNRT	F	NON-FINAL ACTION E-MAILED	005
11/12/2013	CNRT	R	NON-FINAL ACTION WRITTEN	004
11/07/2013	DOCK	D	ASSIGNED TO EXAMINER	003
08/12/2013	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
08/08/2013	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Maury M. Tepper, III
CORRESPONDENCE ADDRESS	MAURY M. TEPPER, III TEPPER & EYSTER, PLLC 3724 BENSON DR RALEIGH, NC 27609
DOMESTIC REPRESENTATIVE	Novartis Pharmaceuticals Corporation

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Novartis AG
ADDRESS	CH-4002 Basel,
ENTITY	03-CORPORATION
CITIZENSHIP	Switzerland

ITU Unit Action [image/jpeg]

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.